- 24-Hour BP Control
- Vs. other ARBs, Boehringer Ingelheim’s Telmisartan has the highest plasma half-life leading to 24-hour BP Control
- Only Telmisartan has the unique Delta Lock structure which contributes to its prolonged duration of BP lowering action
- Telmisartan is more effective than ramipril throughout the 24-h period and during the early morning BP surge
- Telmisartan as initial dose for hypertension
- Start Early with Telmisartan in Mild-to-moderate Hypertensive Patients
- The multiple benefits of Telmisartan-based SPCs are aligned with updated standards of care from international guidelines1
- Start with Boehringer Ingelheim’s Telmisartan in mild to moderate hypertensive patients
- Mild to Moderate Hypertension - Thomas Unger - Telmisartan
- CV Protection
- Cardiovascular Protection
- Boehringer Ingelheim’s Telmisartan is the ONLY ARB INDICATED* to reduce both CV morbidity and mortality for high-risk patients
- Boehringer Ingelheim’s Telmisartan is the ONLY ARB that is INDICATED* to reduce both CV morbidity and mortality for high-risk patients
- HPN with T2D - Thomas Unger - Telmisartan
- Role of Twynsta - Thomas Unger - Telmisartan
- High Risk HPN Patients - Thomas Unger - Telmisartan
- Renal Benefits
- Boehringer Ingelheim’s Telmisartan preserves renal function in hypertensive patients with type 2 diabetic nephropathy
- Boehringer Ingelheim’s Telmisartan reduces proteinuria in hypertensive patients with diabetic nephropathy
- Telmisartan is superior to losartan in reducing proteinuria in hypertensive patients with diabetic nephropathy
- Boehringer Ingelheim's Telmisartan provides CV and renal benefits to T2D hypertensive patients with diabetic nephropathy
- Boehringer Ingelheim’s Telmisartan provides renal benefits to high-risk* hypertensive patients
- HPN with CKD - Thomas Unger - Telmisartan
- Prescribing Information
- Quality and Legacy
- Cost Effectiveness
